Helping biotech being Nasdaq ready

“Financial communication” is generally not natural for biotech executives, and cannot be improvised

Biotechs must regularly communicate and discuss with current and future investors their operational and financial results, as well as their perspectives.

Financial communication is a strategic form of institutional communication intended to strengthen company credibility, and investors confidence in future opportunities and perspectives.

Financial Communication is not a natural exercise for many entrepreneurs and executives, primarily focused on day-to-day operational management and advancing science.

3 pitfalls are often observed:
– communication is far too scientific or technical
– messages are too positive and incomplete vis-à-vis capital markets
– approach to communication is not very structured nor very rigorous

Helping biotech being Nasdaq ready

“Financial communication” is generally not natural for biotech executives, and cannot be improvised.

Biotechs must regularly communicate and discuss with current and future investors their operational and financial results, as well as their perspectives.

Financial communication is a strategic form of institutional communication intended to strengthen company credibility, and investors confidence in future opportunities and perspectives.

Financial Communication is not a natural exercise for many entrepreneurs and executives, primarily focused on day-to-day operational management and advancing science.

3 pitfalls are often observed:
– communication is far too scientific or technical
– messages are too positive and incomplete vis-à-vis capital markets
– approach to communication is not very structured nor very rigorous

Our Services

Objectives:
Help management improve the quality and reliability, and therefore the efficiency, of its financial communication.

We support, on an ad hoc or recurring basis, the following 3 key areas:
– Strategic review of company financial communication practices
– Public speaking training for executives spokespersons
– IR competencies upgrade for newly appointed Investor Relations Officer

Target audience:
Mainly executives (CEO, CFO, etc.), and those in charge of Investor Relations, in biotechs, whether listed or not
– Some “prescribers” (investors, investment banks, biotech clusters and incubators, communication agencies etc.) who would like to suggest or offer our services

√  Strategic review of financial communication practices
√  Recommendations, implementation and follow-up

Specific objectives
Provide executives the opportunity to identify and select improvements in their current financial communication practices.

» Assessment and discussion with the management team, in particular on:

  • Equity Story (vs. Investment Case)
  • decision and validation procedures vs. Market Abuse Regulation (MAR)
  • modeling elements provided to markets
  • organization of the financial communication / IR function, its objectives, its tools and advisors
  • financial communication strategy / IR programs
  • Individual / retail shareholders, ESG / CSR …

√  Public speaking training for executives spokespersons
√  Coaching and follow-up


Specific objectives

Improve company spokespersons self-confidence as well as the relevance of their messages to investors and analysts.

» Q&A training sessions, combining theory and practice, in particular on the following points:

  • overall principles of communication with capital markets, biotech specificities
  • helping formulation specific key messages, appropriate for investors, and Storytelling
  • practicing anticipated and difficult or unanticipated questions
  • managing market expectations

√  IR competencies upgrade for newly appointed Investor Relations personnels
√  Training and follow-up

Specific objectives
Increase the influence of the IR function on the quality of business decisions, by taking better account of market expectations; secondly, increase the credibility and reputation of the management team.

» Training covering:

  • overall principles of financial communication and biotech specificity
  • mandatory communication tools, and optional tools
  • support to management
  • professional technical tools and consulting agencies
  • other (ESG / SRI aspects, crisis communication, etc. )

√  One-off ad-hoc support  
√  Execution, operational implementation, coaching 

Examples
– Support during changes in IR processes and practices
– Implementation of routine IR Reporting for management and board
– Implementation of MiFID II mitigating strategies

– Cohesion between operational teams, and with the Board
– Alignment and validation of key messages
– Conduct of Perception Study / 360 Study
– Help during the preparation of major events (IPO, Capital Market Day / R&D Day…)
– Retail Shareholders strategies more in French » ]

– …

Our Clients